Stay informed about the latest diabetes news and research, including medical discoveries, treatment developments, clinical studies, technology and emerging health insights.
A six-month trial suggests that limiting eating window may improve blood glucose management for some adults with Type 1 diabetes, without immediate safety risks, prompting calls for larger studies. A six-month randomised trial led by researchers at the University of…
Michel J. Shami from Texas Retina has been invited to brief investigators on three pivotal studies exploring innovative treatments and intervention timings for retinal diseases, marking a significant step in enhancing sight preservation amid rising diabetes prevalence. Texas Retina’s Michel…
Pharmacists express heightened concerns over the safety, authenticity, and regulation of compounded GLP-1 medicines as the FDA moves towards tighter rules amid rising demand and market complexities. Pharmacists are increasingly being asked to help patients navigate a fast-changing market for…
Greenstone Biosciences has received funding from Breakthrough T1D to develop a pioneering research platform using induced pluripotent stem cells and organoids, aiming to uncover why insulin-producing beta cells become vulnerable in type 1 diabetes. Greenstone Biosciences has won funding from…
Researchers continue to explore metformin as a possible drug to slow certain aspects of ageing, but evidence supporting its effectiveness remains inconsistent. While it influences various ageing pathways, its role in extending healthspan or lifespan in humans is still unproven,…
As millions take newer dual-action obesity drugs, emerging research uncovers promising benefits like reduced inflammation and cardiovascular risks, alongside concerns over muscle loss and nutrient deficiencies, prompting calls for further targeted studies. Millions of people are now taking GLP-1 receptor…
Researchers at Koç University report that disabling candidate genes RNLS or HIVEP2 does not suffice to prevent rejection of transplanted pancreatic beta cells, underscoring challenges in immune protection for diabetes therapies. Gene editing has fallen short in a new attempt…
New observational research indicates that newer GLP-1 receptor agonists, semaglutide and tirzepatide, may be associated with reduced alcohol-related hospital admissions in adults with type 2 diabetes, obesity, or alcohol use disorder, though further trials are necessary to confirm these findings.…
A recent study suggests that dihydropyridine calcium-channel blockers, commonly prescribed for hypertension in diabetic patients, may be associated with increased risks of kidney deterioration, prompting calls for further investigation into safer treatment strategies. New findings presented at the 63rd European…
California has distributed over 120,000 affordable insulin pens via its CalRx programme, challenging Big Pharma and seeking to expand access amidst industry pushback and low consumer awareness. California’s push into the insulin market is starting to move from symbolism to…
Amylyx Pharmaceuticals reports successful Phase 3 trial of avexitide, potentially paving the way for the first approved treatment for post-bariatric hypoglycaemia, affecting around 160,000 patients in the US. Amylyx Pharmaceuticals said its experimental drug avexitide met the main goal in…
Despite fiscal measures including a sugar tax, Mauritius faces a surging diabetes epidemic driven by lifestyle and societal factors, prompting calls for comprehensive behavioural change to turn the tide. Mauritius is confronting one of the world’s heaviest diabetes burdens, with…
